8 March 2018
Cytox awarded new Innovate UK funding for Alzheimer’s disease testing
8 March 2018: Oxford & Manchester, UK. Cytox, an emerging precision medicine leader providing genetic testing for Alzheimer’s disease, is pleased to announce that, in partnership with Cardiff University, the company has been awarded funding by Innovate UK. The award is...
1 March 2018
Oxford BioTherapeutics Appoints Chief Medical Officer, Abderrahim Fandi M.D., Ph.D.
OXFORD, UK and SAN JOSE, CA - March 1st, 2018 - Oxford BioTherapeutics (“OBT”), a clinical stage oncology company with a pipeline of immuno-oncology and antibody-drug conjugate based therapies, today announced the appointment of Abderrahim (Rahim) Fandi, M.D., Ph.D.
20 February 2018
r2c Online connects over 50,000 fleet and workshop users
r2c Online now bring fifty thousand fleet and workshop users together for more efficient digital collaboration. As part of the r2c Online network, these users can connect and collaborate with their supply chain in real-time to achieve best practice compliance. Nick Walls...
6 February 2018
R2C software saves Allan Morris Transport £100,000
Allan Morris Transport has revealed savings of over £100,000 since adopting R2C Online’s fleet management software. Having used R2C’s compliance management platform in 2012, Terry Axon, operations director at Allan Morris Transport, has not looked back since.
1 February 2018
Manchester Imaging Raises £600k to Launch Dental Diagnostic Software
Manchester, UK, 1st February 2018 - Manchester Imaging, a dental diagnostic software company, today announced that it has raised a £600,000 investment from the GM&C Life Sciences Fund, managed by Catapult Ventures, and NPIF - Mercia Equity Finance, which is managed by...
31 January 2018
Australia receives first two revolutionary skin cancer diagnostic machines from VivoSight
Having existed in Europe for some time, the latest technology for early identification and assisted treatment of skin cancer has been installed at two Sydney clinics. When a skin cancer is suspected, a biopsy is often necessary to confirm the diagnosis. A biopsy is also often...
30 January 2018
Acea Health announces funding from Catapult Ventures and PUBLIC to launch innovative digital dental and medical consent platform - Flynotes
Alderley Park, UK – 24th January 2018. Acea Health, a digital healthcare company, today announced the completion of a seed funding round to launch Flynotes – its new digital consent platform. The funding comes from the GM&C Life Sciences Fund, managed by Catapult...
22 January 2018
Yospace and NexPlayer announce integration
Deal will allow broadcasters to monetise live streams on HTML5 platforms … Yospace and NexPlayer have announced a partnership to make it easier for broadcasters to monetise their live streams. Yospace’s HTML5 SDK has been pre-integrated into the NexPlayer HTML5 player...
18 January 2018
e-Therapeutics to collaborate with Intellegens and Biorelate to enhance and extend its AI technology capabilities
e-Therapeutics is to collaborate with Intellegens and Biorelate to enhance and extend its artificial intelligence technology capabilities. e-Therapeutics said both companies had artificial intelligence (AI) tools which, after pilot studies, had been proven to enhance...
11 January 2018
SurgaColl Holdings Ltd announces Series A funding, opens HQ in Alderley Park
Alderley Park, UK – 10th January 2018. SurgaColl, a regenerative medicine company focussed on tissue repair, today announced the completion of its Series A funding, led by the GM&C Life Sciences Fund, and including investment from Julz Co, a US-based healthcare fund.